Prism Health North Texas, a community health center, participated in clinical trials for Merck's new HIV treatment, Idvynso.
A major study presented at ESCMID Global 2026 has found that antiretroviral therapy (ART) reduces accelerated biological ...
By Christy Santhosh and Sriparna Roy April 21 (Reuters) - The U.S. Food and Drug Administration has approved Merck's ...
While rates of HIV infection in the black community have fallen in recent years, fewer of those infected receive treatment and achieve viral suppression than whites, according to a recent CDC study ...
The fall and now rise of HIV. A sobering observation has doctors concerned. And now, there’s a call to action to reverse the ...
Hosted on MSN
HIV rates highest in the American South, despite effective treatments: A clash between culture and public health
The American South has the highest HIV rates in the country, accounting for more than half of new HIV diagnoses nationwide in 2023. This is despite the growing availability of a highly effective HIV ...
Researchers found that certain immune cells, genes, and the drug metformin may help keep HIV dormant after treatment stops, ...
A study in Health Economics uncovered an unintended consequence of a major medical breakthrough: while the availability of ...
Anemia is a common complication of HIV. There are numerous possible causes, including HIV itself, related infections, and some HIV medications. Taking certain medications and adjusting nutrition may ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results